INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation
BIT:1ISRG • US46120E6023
Current stock price
397.85 EUR
-0.15 (-0.04%)
Last:
This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1ISRG.MI Profitability Analysis
1.1 Basic Checks
- In the past year 1ISRG was profitable.
- 1ISRG had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ISRG has been profitable.
- 1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- 1ISRG has a Return On Assets of 13.96%. This is amongst the best in the industry. 1ISRG outperforms 96.72% of its industry peers.
- 1ISRG has a better Return On Equity (16.02%) than 88.52% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 13.95%, 1ISRG belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 9.41%.
- The 3 year average ROIC (12.43%) for 1ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROIC | 13.95% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1.3 Margins
- The Profit Margin of 1ISRG (28.38%) is better than 100.00% of its industry peers.
- 1ISRG's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 29.35%, 1ISRG belongs to the top of the industry, outperforming 98.36% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1ISRG has grown nicely.
- The Gross Margin of 1ISRG (66.00%) is better than 73.77% of its industry peers.
- In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% |
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
2. 1ISRG.MI Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
- 1ISRG has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, 1ISRG has more shares outstanding
- There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- 1ISRG has an Altman-Z score of 38.87. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
- 1ISRG has a Altman-Z score of 38.87. This is amongst the best in the industry. 1ISRG outperforms 98.36% of its industry peers.
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 38.87 |
ROIC/WACC1.56
WACC8.95%
2.3 Liquidity
- A Current Ratio of 4.87 indicates that 1ISRG has no problem at all paying its short term obligations.
- 1ISRG has a Current ratio of 4.87. This is amongst the best in the industry. 1ISRG outperforms 95.08% of its industry peers.
- 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- 1ISRG's Quick ratio of 3.96 is amongst the best of the industry. 1ISRG outperforms 96.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 |
3. 1ISRG.MI Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 25.92% over the past year.
- Measured over the past years, 1ISRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
- 1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.51%.
- The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%
3.2 Future
- 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.55% yearly.
- 1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.00% yearly.
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. 1ISRG.MI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 48.46, which means the current valuation is very expensive for 1ISRG.
- Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
- Compared to an average S&P500 Price/Earnings ratio of 26.77, 1ISRG is valued quite expensively.
- A Price/Forward Earnings ratio of 39.95 indicates a quite expensive valuation of 1ISRG.
- 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 67.21% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of 1ISRG to the average of the S&P500 Index (21.75), we can say 1ISRG is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.46 | ||
| Fwd PE | 39.95 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 65.57% of the companies listed in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 66.45 | ||
| EV/EBITDA | 42.31 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of 1ISRG may justify a higher PE ratio.
- 1ISRG's earnings are expected to grow with 14.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.36
PEG (5Y)2.26
EPS Next 2Y14.29%
EPS Next 3Y14.44%
5. 1ISRG.MI Dividend Analysis
5.1 Amount
- 1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1ISRG (4/28/2026, 7:00:00 PM)
397.85
-0.15 (-0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth60.87
Earnings (Last)04-21 2026-04-21/amc
Earnings (Next)07-20 2026-07-20/amc
Inst Owners88.75%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap141.30B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts79.02
Price Target516.08 (29.72%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-3.34%
PT rev (3m)-2.8%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-0.7%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.46 | ||
| Fwd PE | 39.95 | ||
| P/S | 16.44 | ||
| P/FCF | 66.45 | ||
| P/OCF | 54.61 | ||
| P/B | 9.28 | ||
| P/tB | 9.49 | ||
| EV/EBITDA | 42.31 |
EPS(TTM)8.21
EY2.06%
EPS(NY)9.96
Fwd EY2.5%
FCF(TTM)5.99
FCFY1.5%
OCF(TTM)7.29
OCFY1.83%
SpS24.2
BVpS42.85
TBVpS41.92
PEG (NY)3.36
PEG (5Y)2.26
Graham Number88.9676 (-77.64%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROCE | 16.01% | ||
| ROIC | 13.95% | ||
| ROICexc | 20.73% | ||
| ROICexgc | 21.4% | ||
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% | ||
| FCFM | 24.75% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 79.72% | ||
| Cap/Sales | 5.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.46% | ||
| Profit Quality | 87.21% | ||
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 | ||
| Altman-Z | 38.87 |
F-Score8
WACC8.95%
ROIC/WACC1.56
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.45%
EBIT Next 3Y21.62%
EBIT Next 5Y17.23%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%
INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
What is the profitability of 1ISRG stock?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.
What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 14.43% in the next year.